{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AhR", "flavonoids", "herbal plants", "immune response", "immunomodulatory"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34249001", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "13"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "24"}], "Language": ["eng"], "ELocationID": ["697663", "10.3389/fimmu.2021.697663"], "Journal": {"ISSN": "1664-3224", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in immunology", "ISOAbbreviation": "Front Immunol"}, "ArticleTitle": "Herbal Plants: The Role of AhR in Mediating Immunomodulation.", "Pagination": {"StartPage": "697663", "MedlinePgn": "697663"}, "Abstract": {"AbstractText": ["The prevalence of chronic inflammatory diseases including inflammatory bowel disease (IBD), autoimmunity and cancer have increased in recent years. Herbal-based compounds such as flavonoids have been demonstrated to contribute to the modulation of these diseases although understanding their mechanism of action remains limited. Flavonoids are able to interact with cellular immune components in a distinct way and influence immune responses at a molecular level. In this mini review, we highlight recent progress in our understanding of the modulation of immune responses by the aryl hydrocarbon receptor (AhR), a ligand-dependent transcription factor whose activity can be regulated by diverse molecules including flavonoids. We focus on the role of AhR in integrating signals from flavonoids to modulate inflammatory responses using <i>in vitro</i> and experimental animal models. We also summarize the limitations of these studies. Medicinal herbs have been widely used to treat inflammatory disorders and may offer a valuable therapeutic strategy to treat aberrant inflammatory responses by modulation of the AhR pathway."], "CopyrightInformation": "Copyright \u00a9 2021 Bungsu, Kifli, Ahmad, Ghani and Cunningham."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB), Institute of Health Sciences, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei."}], "LastName": "Bungsu", "ForeName": "Izzah", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB), Institute of Health Sciences, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei."}], "LastName": "Kifli", "ForeName": "Nurolaini", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB), Institute of Health Sciences, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei."}], "LastName": "Ahmad", "ForeName": "Siti Rohaiza", "Initials": "SR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB), Institute of Health Sciences, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei."}], "LastName": "Ghani", "ForeName": "Hazim", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB), Institute of Health Sciences, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei."}], "LastName": "Cunningham", "ForeName": "Anne Catherine", "Initials": "AC"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Immunol", "NlmUniqueID": "101560960", "ISSNLinking": "1664-3224"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "AHR protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Basic Helix-Loop-Helix Transcription Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Aryl Hydrocarbon"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy", "immunology"], "DescriptorName": "Autoimmune Diseases"}, {"QualifierName": ["immunology"], "DescriptorName": "Basic Helix-Loop-Helix Transcription Factors"}, {"QualifierName": ["chemistry", "immunology", "therapeutic use"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Immunomodulation"}, {"QualifierName": ["drug therapy", "immunology"], "DescriptorName": "Inflammation"}, {"QualifierName": ["drug therapy", "immunology"], "DescriptorName": "Inflammatory Bowel Diseases"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["immunology"], "DescriptorName": "Receptors, Aryl Hydrocarbon"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "Signal Transduction"}], "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gonzalez H, Hagerling C, Werb Z. Roles of the Immune System in Cancer: From Tumor Initiation to Metastatic Progression. Genes Dev (2018) 32:1267\u201384. \u00a010.1101/GAD.314617.118", "ArticleIdList": ["10.1101/GAD.314617.118", "PMC6169832", "30275043"]}, {"Citation": "P\u00e9rez-Cano FJ, Castell M. Flavonoids, Inflammation and Immune System. Nutrients (2016) 8:8\u201311. \u00a010.3390/nu8100659", "ArticleIdList": ["10.3390/nu8100659", "PMC5084045", "27775647"]}, {"Citation": "Vezza T, Rodr\u00edguez-Nogales A, Algieri F, Utrilla MP, Rodriguez-Cabezas ME, Galvez J. Flavonoids in Inflammatory Bowel Disease: A Review. Nutrients (2016) 8:1\u201322. \u00a010.3390/nu8040211", "ArticleIdList": ["10.3390/nu8040211", "PMC4848680", "27070642"]}, {"Citation": "Rengasamy KRR, Khan H, Gowrishankar S, Lagoa RJL, Mahomoodally FM, Khan Z, et al. . The Role of Flavonoids in Autoimmune Diseases: Therapeutic Updates. Pharmacol Ther (2019) 194:107\u201331. \u00a010.1016/j.pharmthera.2018.09.009", "ArticleIdList": ["10.1016/j.pharmthera.2018.09.009", "30268770"]}, {"Citation": "Wang XS, Cao F, Zhang Y, Pan HF. Therapeutic Potential of Aryl Hydrocarbon Receptor in Autoimmunity. Inflammopharmacology (2020) 28:63\u201381. \u00a010.1007/s10787-019-00651-z", "ArticleIdList": ["10.1007/s10787-019-00651-z", "31617124"]}, {"Citation": "Rodr\u00edguez-Garc\u00eda C, S\u00e1nchez-Quesada C, Gaforio JJ, Gaforio JJ. Dietary Flavonoids as Cancer Chemopreventive Agents: An Updated Review of Human Studies. Antioxidants (2019) 8:1\u201323. \u00a010.3390/antiox8050137", "ArticleIdList": ["10.3390/antiox8050137", "PMC6562590", "31109072"]}, {"Citation": "Bisol \u00c2, de Campos PS, Lamers ML. Flavonoids as Anticancer Therapies: A Systematic Review of Clinical Trials. Phytother Res (2020) 34:568\u201382. \u00a010.1002/ptr.6551", "ArticleIdList": ["10.1002/ptr.6551", "31752046"]}, {"Citation": "Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as Anticancer Agents. Nutrients (2020) 12:1\u201325. \u00a010.3390/nu12020457", "ArticleIdList": ["10.3390/nu12020457", "PMC7071196", "32059369"]}, {"Citation": "Panche AN, Diwan AD, Chandra SR. Flavonoids: An Overview. J Nutr Sci (2016) 5:1\u201315. \u00a010.1017/jns.2016.41", "ArticleIdList": ["10.1017/jns.2016.41", "PMC5465813", "28620474"]}, {"Citation": "Jantan I, Haque MA, Arshad L, Harikrishnan H, Septama AW, Mohamed-Hussein ZA. Dietary Polyphenols Suppress Chronic Inflammation by Modulation of Multiple Inflammation-Associated Cell Signaling Pathways. J Nutr Biochem (2021) 93:108634. \u00a010.1016/j.jnutbio.2021.108634", "ArticleIdList": ["10.1016/j.jnutbio.2021.108634", "33794330"]}, {"Citation": "Liu SH, Lin CH, Hung SK, Chou JH, Chi CW, Fu SL. Fisetin Inhibits Lipopolysaccharide-Induced Macrophage Activation and Dendritic Cell Maturation. J Agric Food Chem (2010) 58:10831\u20139. \u00a010.1021/jf1017093", "ArticleIdList": ["10.1021/jf1017093", "20923145"]}, {"Citation": "Huang R-Y, Yu Y-L, Cheng W-C, OuYang C-N, Fu E, Chu C-L. Immunosuppressive Effect of Quercetin on Dendritic Cell Activation and Function. J Immunol (2010) 184:6815\u201321. \u00a010.4049/jimmunol.0903991", "ArticleIdList": ["10.4049/jimmunol.0903991", "20483746"]}, {"Citation": "Xia N, Chen G, Liu M, Ye X, Pan Y, Ge J, et al. . Anti-Inflammatory Effects of Luteolin on Experimental Autoimmune Thyroiditis in Mice. Exp Ther Med (2016) 12:4049\u201354. \u00a010.3892/etm.2016.3854", "ArticleIdList": ["10.3892/etm.2016.3854", "PMC5228320", "28101184"]}, {"Citation": "Wang J, Li TM, Zang L, Pan X, Wang S, Wu Y, et al. . Apigenin Inhibits Human SW620 Cell Growth by Targeting Polyamine Catabolism. Evid Based Complement Alternat Med (2017) 2017:1\u201312. \u00a010.1155/2017/3684581", "ArticleIdList": ["10.1155/2017/3684581", "PMC5442336", "28572828"]}, {"Citation": "H\u00e4m\u00e4l\u00e4inen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-Inflammatory Effects of Flavonoids: Genistein, Kaempferol, Quercetin, and Daidzein Inhibit STAT-1 and NF-\u03baB Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit Only NF-\u03baB Activation Along With Their Inhibitory Effect on I. Mediators Inflamm (2007) 2007:1\u201310. \u00a010.1155/2007/45673", "ArticleIdList": ["10.1155/2007/45673", "PMC2220047", "18274639"]}, {"Citation": "Pei R, Liu X, Bolling B. Flavonoids and Gut Health. Curr Opin Biotechnol (2020) 61:153\u20139. \u00a010.1016/j.copbio.2019.12.018", "ArticleIdList": ["10.1016/j.copbio.2019.12.018", "31954357"]}, {"Citation": "Denison MS, Nagy SR. Activation of the Aryl Hydrocarbon Receptor by Structurally\u00a0Diverse Exogenous and Endogenous Chemicals. Annu Rev Pharmacol Toxicol (2003) 43:309\u201334. \u00a010.1146/annurev.pharmtox.43.100901.135828", "ArticleIdList": ["10.1146/annurev.pharmtox.43.100901.135828", "12540743"]}, {"Citation": "Nguyen LP, Bradfield CA. The Search for Endogenous Activators of the Aryl H. Chem Res Toxicol (2008) 21(1):102\u201316. 10.1021/tx7001965", "ArticleIdList": ["10.1021/tx7001965", "PMC2572005", "18076143"]}, {"Citation": "Jin UH, Park H, Li X, Davidson LA, Allred C, Patil B, et al. . Structure-Dependent Modulation of Aryl Hydrocarbon Receptor-Mediated Activities by Flavonoids. Toxicol Sci (2018) 164:205\u201317. \u00a010.1093/toxsci/kfy075", "ArticleIdList": ["10.1093/toxsci/kfy075", "PMC6016704", "29584932"]}, {"Citation": "Wheeler MA, Rothhammer V, Quintana FJ. Control of Immune-Mediated Pathology Via the Aryl Hydrocarbon Receptor. J Biol Chem (2017) 292:12383\u20139. \u00a010.1074/jbc.R116.767723", "ArticleIdList": ["10.1074/jbc.R116.767723", "PMC5535014", "28615443"]}, {"Citation": "Poland A, Knutson JC. 2,3,7,8-Tetrachlorodibenzo- P -Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of Toxicity. Annu Rev Pharmacol Toxicol (1982) 22:517\u201354. \u00a010.1146/annurev.pa.22.040182.002505", "ArticleIdList": ["10.1146/annurev.pa.22.040182.002505", "6282188"]}, {"Citation": "Larigot L, Juricek L, Dairou J, Coumoul X. AhR Signaling Pathways and Regulatory Functions. Biochim Open (2018) 7:1\u20139. \u00a010.1016/j.biopen.2018.05.001", "ArticleIdList": ["10.1016/j.biopen.2018.05.001", "PMC6039966", "30003042"]}, {"Citation": "Barroso A, Mahler JV, Fonseca-Castro PH, Quintana FJ. The Aryl Hydrocarbon Receptor and the Gut\u2013Brain Axis. Cell Mol Immunol (2021) 18:259\u201368. \u00a010.1038/s41423-020-00585-5", "ArticleIdList": ["10.1038/s41423-020-00585-5", "PMC8027889", "33408340"]}, {"Citation": "Guti\u00e9rrez-V\u00e1zquez C, Quintana FJ. Regulation of the Immune Response by the Aryl Hydrocarbon Receptor. Immunity (2018) 48:19\u201333. \u00a010.1016/j.immuni.2017.12.012", "ArticleIdList": ["10.1016/j.immuni.2017.12.012", "PMC5777317", "29343438"]}, {"Citation": "Rothhammer V, Quintana FJ. The Aryl Hydrocarbon Receptor: An Environmental Sensor Integrating Immune Responses in Health and Disease. Nat Rev Immunol (2019) 19:184\u201397. \u00a010.1038/s41577-019-0125-8", "ArticleIdList": ["10.1038/s41577-019-0125-8", "30718831"]}, {"Citation": "Stockinger B, Di MP, Gialitakis M, Duarte JH. The Aryl Hydrocarbon Receptor: Multitasking in the Immune System. Annu Rev Immunol (2014) 32:403\u201332. \u00a010.1146/annurev-immunol-032713-120245", "ArticleIdList": ["10.1146/annurev-immunol-032713-120245", "24655296"]}, {"Citation": "Hankinson O. Role of Coactivators in Transcriptional Activation by the Aryl Hydrocarbon Receptor. Arch Biochem Biophys (2005) 433:379\u201386. \u00a010.1016/j.abb.2004.09.031", "ArticleIdList": ["10.1016/j.abb.2004.09.031", "15581594"]}, {"Citation": "Puga A, Barnes SJ, Dalton TP, Chang CY, Knudsen ES, Maier MA. Aromatic Hydrocarbon Receptor Interaction With the Retinoblastoma Protein Potentiates Repression of E2F-Dependent Transcription and Cell Cycle Arrest. J Biol Chem (2000) 275:2943\u201350. \u00a010.1074/jbc.275.4.2943", "ArticleIdList": ["10.1074/jbc.275.4.2943", "10644764"]}, {"Citation": "Vogel CFA, Sciullo E, Matsumura F. Involvement of RelB in Aryl Hydrocarbon Receptor-Mediated Induction of Chemokines. Biochem Biophys Res Commun (2007) 363:722\u20136. \u00a010.1016/j.bbrc.2007.09.032", "ArticleIdList": ["10.1016/j.bbrc.2007.09.032", "PMC4275028", "17900530"]}, {"Citation": "Marlowe JL, Knudsen ES, Schwemberger S, Puga A. The Aryl Hydrocarbon Receptor Displaces p300 From E2F-Dependent Promoters and Represses S Phase-Specific Gene Expression. J Biol Chem (2004) 279:29013\u201322. \u00a010.1074/jbc.M404315200", "ArticleIdList": ["10.1074/jbc.M404315200", "15123621"]}, {"Citation": "Wright EJ, Pereira De Castro K, Joshi AD, Elferink CJ. Canonical and Non-Canonical Aryl Hydrocarbon Receptor Signaling Pathways. Curr Opin Toxicol (2017) 2:87\u201392. \u00a010.1016/j.cotox.2017.01.001", "ArticleIdList": ["10.1016/j.cotox.2017.01.001", "PMC7158745", "32296737"]}, {"Citation": "Jackson DP, Li H, Mitchell KA, Joshi AD, Elferink CJ. Ah Receptor-Mediated Suppression of Liver Regeneration Through NC-XRE-Driven p21Cip1 Expression. Mol Pharmacol (2014) 85:533\u201341. \u00a010.1124/mol.113.089730", "ArticleIdList": ["10.1124/mol.113.089730", "PMC3965890", "24431146"]}, {"Citation": "Garcia GR, Goodale BC, Wiley MW, La Du JK, Hendrix DA, Tanguay RL. In Vivo Characterization of an AHR-Dependent Long Noncoding RNA Required for Proper Sox9b Expression. Mol Pharmacol (2017) 91:609\u201319. \u00a010.1124/mol.117.108233", "ArticleIdList": ["10.1124/mol.117.108233", "PMC5438132", "28385905"]}, {"Citation": "Wang S, Hankinson O. Functional Involvement of the Brahma/SWI2-Related Gene 1 Protein in Cytochrome P4501A1 Transcription Mediated by the Aryl Hydrocarbon Receptor Complex. J Biol Chem (2002) 277:11821\u20137. \u00a010.1074/jbc.M110122200", "ArticleIdList": ["10.1074/jbc.M110122200", "11805098"]}, {"Citation": "Beischlag TV, Wang S, Rose DW, Torchia J, Reisz-Porszasz S, Muhammad K, et al. . Recruitment of the NCoA/SRC-1/p160 Family of Transcriptional Coactivators by the Aryl Hydrocarbon Receptor/Aryl Hydrocarbon Receptor Nuclear Translocator Complex. Mol Cell Biol (2002) 22:4319\u201333. \u00a010.1128/mcb.22.12.4319-4333.2002", "ArticleIdList": ["10.1128/mcb.22.12.4319-4333.2002", "PMC133867", "12024042"]}, {"Citation": "Schnekenburger M, Peng L, Puga A. HDAC1 Bound to the Cyp1a1 Promoter Blocks Histone Acetylation Associated With Ah Receptor-Mediated Trans-Activation. Biochim Biophys Acta - Gene Struct Expr (2007) 1769:569\u201378. \u00a010.1016/j.bbaexp.2007.07.002", "ArticleIdList": ["10.1016/j.bbaexp.2007.07.002", "PMC2083643", "17707923"]}, {"Citation": "Murray IA, Reen RK, Leathery N, Ramadoss P, Bonati L, Gonzalez FJ, et al. . Evidence That Ligand Binding Is a Key Determinant of Ah Receptor-Mediated Transcriptional Activity. Arch Biochem Biophys (2005) 442:59\u201371. \u00a010.1016/j.abb.2005.07.014", "ArticleIdList": ["10.1016/j.abb.2005.07.014", "16137638"]}, {"Citation": "Han Z, Miwa Y, Obikane H, Mitsumata M, Takahashi-Yanaga F, Morimoto S, et al. . Aryl Hydrocarbon Receptor Mediates Laminar Fluid Shear Stress-Induced CYP1A1 Activation and Cell Cycle Arrest in Vascular Endothelial Cells. Cardiovasc Res (2008) 77:809\u201318. \u00a010.1093/cvr/cvm095", "ArticleIdList": ["10.1093/cvr/cvm095", "18065768"]}, {"Citation": "Stockinger B, Hirota K, Duarte J, Veldhoen M. External Influences on the Immune System Via Activation of the Aryl Hydrocarbon Receptor. Semin Immunol (2011) 23:99\u2013105. \u00a010.1016/j.smim.2011.01.008", "ArticleIdList": ["10.1016/j.smim.2011.01.008", "21288737"]}, {"Citation": "Gandhi R, Kumar D, Burns EJ, Nadeau M, Dake B, Laroni A, et al. . Activation of the Aryl Hydrocarbon Receptor Induces Human Type 1 Regulatory T Cell-Like and Foxp3+ Regulatory T Cells. Nat Immunol (2010) 11:846\u201353. \u00a010.1038/ni.1915", "ArticleIdList": ["10.1038/ni.1915", "PMC2929008", "20676092"]}, {"Citation": "Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, et al. . Control of Treg and TH17 Cell Differentiation by the Aryl Hydrocarbon Receptor. Nature (2008) 453:65\u201371. \u00a010.1038/nature06880", "ArticleIdList": ["10.1038/nature06880", "18362915"]}, {"Citation": "Mascanfroni ID, Takenaka MC, Yeste A, Patel B, Wu Y, Kenison JE, et al. . Metabolic Control of Type 1 Regulatory T Cell Differentiation by AHR and HIF1-\u03b1. Nat Med (2015) 21:638\u201346. \u00a010.1038/nm.3868", "ArticleIdList": ["10.1038/nm.3868", "PMC4476246", "26005855"]}, {"Citation": "Basu R, O\u2019Quinn DB, Silberger DJ, Schoeb TR, Fouser L, Ouyang W, et al. . Th22 Cells Are an Important Source of IL-22 for Host Protection Against Enteropathogenic Bacteria. Immunity (2012) 37:1061\u201375. \u00a010.1016/j.immuni.2012.08.024", "ArticleIdList": ["10.1016/j.immuni.2012.08.024", "PMC3678257", "23200827"]}, {"Citation": "Winans B, Nagari A, Chae M, Post CM, Ko C-I, Puga A, et al. . Linking the Aryl Hydrocarbon Receptor With Altered DNA Methylation Patterns and Developmentally Induced Aberrant Antiviral CD8 + T Cell Responses. J\u00a0Immunol (2015) 194:4446\u201357. \u00a010.4049/jimmunol.1402044", "ArticleIdList": ["10.4049/jimmunol.1402044", "PMC4402273", "25810390"]}, {"Citation": "Vaidyanathan B, Chaudhry A, Yewdell WT, Angeletti D, Yen WF, Wheatley AK, et al. . The Aryl Hydrocarbon Receptor Controls Cell-Fate Decisions in B Cells. J Exp Med (2017) 214:197\u2013208. \u00a010.1084/jem.20160789", "ArticleIdList": ["10.1084/jem.20160789", "PMC5206498", "28011866"]}, {"Citation": "Jiang YZ, Wang K, Fang R, Zheng J. Expression of Aryl Hydrocarbon Receptor in Human Placentas and Fetal Tissues. J Histochem Cytochem (2010) 58:679\u201385. \u00a010.1369/jhc.2010.955955", "ArticleIdList": ["10.1369/jhc.2010.955955", "PMC2907273", "20354149"]}, {"Citation": "Esser C, Rannug A. The Aryl Hydrocarbon Receptor in Barrier Organ Physiology, Immunology, and Toxicology. Pharmacol Rev (2015) 67:259\u201379. \u00a010.1124/pr.114.009001", "ArticleIdList": ["10.1124/pr.114.009001", "25657351"]}, {"Citation": "Metidji A, Omenetti S, Crotta S, Li Y, Nye E, Ross E, et al. . The Environmental Sensor AHR Protects From Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity. Immunity (2018) 49:353\u201362.e5. \u00a010.1016/j.immuni.2018.07.010", "ArticleIdList": ["10.1016/j.immuni.2018.07.010", "PMC6104739", "30119997"]}, {"Citation": "Li Y, Innocentin S, Withers DR, Roberts NA, Gallagher AR, Grigorieva EF, et al. . Exogenous Stimuli Maintain Intraepithelial Lymphocytes Via Aryl Hydrocarbon Receptor Activation. Cell (2011) 147:629\u201340. \u00a010.1016/j.cell.2011.09.025", "ArticleIdList": ["10.1016/j.cell.2011.09.025", "21999944"]}, {"Citation": "Li S, Bostick JW, Zhou L. Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor. Front Immunol (2018) 8:1909. \u00a010.3389/fimmu.2017.01909", "ArticleIdList": ["10.3389/fimmu.2017.01909", "PMC5760495", "29354125"]}, {"Citation": "Suh J, Jeon YJ, Kim HM, Kang JS, Kaminski NE, Yang KH. Aryl Hydrocarbon Receptor-Dependent Inhibition of AP-1 Activity by 2,3,7,8-Tetrachlorodibenzo-P-Dioxin in Activated B Cells. Toxicol Appl Pharmacol (2002) 181:116\u201323. \u00a010.1006/taap.2002.9403", "ArticleIdList": ["10.1006/taap.2002.9403", "12051995"]}, {"Citation": "Boverhof DR, Tam E, Harney AS, Crawford RB, Kaminski NE, Zacharewski TR. 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Suppressor of Cytokine Signaling 2 in Murine B Cells. Mol Pharmacol (2004) 66:1662\u201370. \u00a010.1124/mol.104.002915", "ArticleIdList": ["10.1124/mol.104.002915", "15371557"]}, {"Citation": "Nguyen NT, Kimura A, Nakahama T, Chinen I, Masuda K, Nohara K, et al. . Aryl Hydrocarbon Receptor Negatively Regulates Dendritic Cell Immunogenicity Via a Kynurenine-Dependent Mechanism. Proc Natl Acad Sci USA (2010) 107:19961\u20136. \u00a010.1073/pnas.1014465107", "ArticleIdList": ["10.1073/pnas.1014465107", "PMC2993339", "21041655"]}, {"Citation": "Thatcher TH, Williams MA, Pollock SJ, Mccarthy CE, Lacy SH, Phipps RP, et al. . Endogenous Ligands of the Aryl Hydrocarbon Receptor Regulate Lung Dendritic Cell Function. Immunology (2016) 147:41\u201354. \u00a010.1111/imm.12540", "ArticleIdList": ["10.1111/imm.12540", "PMC4693882", "26555456"]}, {"Citation": "Jurado-Manzano BB, Zavala-Reyes D, Turrubiartes-Mart\u00ednez EA, Portales-P\u00e9rez DP, Gonz\u00e1lez-Amaro R, Layseca-Espinosa E. FICZ Generates Human tDCs That Induce CD4+ CD25high Foxp3+ Treg-Like Cell Differentiation. Immunol Lett (2017) 190:84\u201392. \u00a010.1016/j.imlet.2017.07.013", "ArticleIdList": ["10.1016/j.imlet.2017.07.013", "28765071"]}, {"Citation": "de Ara\u00fajo EF, Feriotti C, de Lima Galdino NA, Preite NW, Calich VLG, Loures FV. The IDO-AhR Axis Controls Th17/Treg Immunity in a Pulmonary Model of Fungal Infection. Front Immunol (2017) 8:880. \u00a010.3389/fimmu.2017.00880", "ArticleIdList": ["10.3389/fimmu.2017.00880", "PMC5523665", "28791025"]}, {"Citation": "Wang C, Ye Z, Kijlstra A, Zhou Y, Yang P. Activation of the Aryl Hydrocarbon Receptor Affects Activation and Function of Human Monocyte-Derived Dendritic Cells. Clin Exp Immunol (2014) 177:521\u201330. \u00a010.1111/cei.12352", "ArticleIdList": ["10.1111/cei.12352", "PMC4226603", "24749687"]}, {"Citation": "Hayday AC. \u03b3\u03b4 T Cell Update: Adaptate Orchestrators of Immune Surveillance. J Immunol (2019) 203:311\u201320. \u00a010.4049/jimmunol.1800934", "ArticleIdList": ["10.4049/jimmunol.1800934", "31285310"]}, {"Citation": "Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. Interleukin-17-Producing \u03b3\u03b4 T Cells Selectively Expand in Response to Pathogen Products and Environmental Signals. Immunity (2009) 31:321\u201330. \u00a010.1016/j.immuni.2009.06.020", "ArticleIdList": ["10.1016/j.immuni.2009.06.020", "19682928"]}, {"Citation": "Marshall NB, Kerkvliet NI. Dioxin And Immune Regulation: Emerging Role Of Aryl Hydrocarbon Receptor in the Generation of Regulatory T Cells. Ann NY Acad Sci (2010) 1183:25\u201337. \u00a010.1111/j.1749-6632.2009.05125.x", "ArticleIdList": ["10.1111/j.1749-6632.2009.05125.x", "PMC4263666", "20146706"]}, {"Citation": "Denison MS, Soshilov AA, He G, Degroot DE, Zhao B. Exactly the Same But Different: Promiscuity and Diversity in the Molecular Mechanisms of Action of the Aryl Hydrocarbon (Dioxin) Receptor. Toxicol Sci (2011) 124:1\u201322. \u00a010.1093/toxsci/kfr218", "ArticleIdList": ["10.1093/toxsci/kfr218", "PMC3196658", "21908767"]}, {"Citation": "Gabriely G, Wheeler MA, Takenaka MC, Quintana FJ. Role of AHR and HIF-1\u03b1 in Glioblastoma Metabolism. Trends Endocrinol Metab (2017) 28:428\u201336. \u00a010.1016/j.tem.2017.02.009", "ArticleIdList": ["10.1016/j.tem.2017.02.009", "PMC5438779", "28318896"]}, {"Citation": "Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, et al. . The Aryl Hydrocarbon Receptor Links TH17-Cell-Mediated Autoimmunity to Environmental Toxins. Nature (2008) 453:106\u20139. \u00a010.1038/nature06881", "ArticleIdList": ["10.1038/nature06881", "18362914"]}, {"Citation": "Veldhoen M, Hirota K, Christensen J, O\u2019Garra A, Stockinger B. Natural Agonists for Aryl Hydrocarbon Receptor in Culture Medium Are Essential for Optimal Differentiation of Th17 T Cells. J Exp Med (2009) 206:43\u20139. \u00a010.1084/jem.20081438", "ArticleIdList": ["10.1084/jem.20081438", "PMC2626686", "19114668"]}, {"Citation": "Wolk K, Haugen HS, Xu W, Witte E, Waggie K, Anderson M, et al. . IL-22 and IL-20 Are Key Mediators of the Epidermal Alterations in Psoriasis While IL-17 and IFN-\u03b3 Are Not. J Mol Med (2009) 87:523\u201336. \u00a010.1007/s00109-009-0457-0", "ArticleIdList": ["10.1007/s00109-009-0457-0", "19330474"]}, {"Citation": "Zenewicz LA, Flavell RA. Recent Advances in IL-22 Biology. Int Immunol (2011) 23:159\u201363. \u00a010.1093/intimm/dxr001", "ArticleIdList": ["10.1093/intimm/dxr001", "21393631"]}, {"Citation": "Zelante T, Iannitti RG, Cunha C, DeLuca A, Giovannini G, Pieraccini G, et al. . Tryptophan Catabolites From Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity Via Interleukin-22. Immunity (2013) 39:372\u201385. \u00a010.1016/j.immuni.2013.08.003", "ArticleIdList": ["10.1016/j.immuni.2013.08.003", "23973224"]}, {"Citation": "Lamas B, Richard ML, Leducq V, Pham HP, Michel ML, Da Costa G, et al. . CARD9 Impacts Colitis by Altering Gut Microbiota Metabolism of Tryptophan Into Aryl Hydrocarbon Receptor Ligands. Nat Med (2016) 22:598\u2013605. \u00a010.1038/nm.4102", "ArticleIdList": ["10.1038/nm.4102", "PMC5087285", "27158904"]}, {"Citation": "Shinde R, McGaha TL. The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment. Trends Immunol (2018) 39:1005\u201320. \u00a010.1016/j.it.2018.10.010", "ArticleIdList": ["10.1016/j.it.2018.10.010", "PMC7182078", "30409559"]}, {"Citation": "Shinde R, Hezaveh K, Halaby MJ, Kloetgen A, Chakravarthy A, Da Silva Medina T, et al. . Apoptotic Cell-Induced AhR Activity Is Required for Immunological Tolerance and Suppression of Systemic Lupus Erythematosus in Mice and Humans Article. Nat Immunol (2018) 19:571\u201382. \u00a010.1038/s41590-018-0107-1", "ArticleIdList": ["10.1038/s41590-018-0107-1", "PMC5976527", "29760532"]}, {"Citation": "Kawai S, Iijima H, Shinzaki S, Hiyama S. Indigo Naturalis Ameliorates Murine Dextran Sodium Sulfate-Induced Colitis Via Aryl Hydrocarbon Receptor Activation. J Gastroenterol (2016) 52:904\u201319. \u00a010.1007/s00535-016-1292-z", "ArticleIdList": ["10.1007/s00535-016-1292-z", "27900483"]}, {"Citation": "Lin YH, Luck H, Khan S, Schneeberger PHH, Tsai S, Clemente-Casares X, et al. . Aryl Hydrocarbon Receptor Agonist Indigo Protects Against Obesity-Related Insulin Resistance Through Modulation of Intestinal and Metabolic Tissue Immunity. Int J Obes (2019) 43:2407\u201321. \u00a010.1038/s41366-019-0340-1", "ArticleIdList": ["10.1038/s41366-019-0340-1", "PMC6892742", "30944419"]}, {"Citation": "Dom\u00ednguez-Acosta O, Vega L, Estrada-Mu\u00f1iz E, Rodr\u00edguez MS, Gonzalez FJ, Elizondo G. Activation of Aryl Hydrocarbon Receptor Regulates the LPS/IFN\u03b3-Induced Inflammatory Response by Inducing Ubiquitin-Proteosomal and Lysosomal Degradation of RelA/P65. Biochem Pharmacol (2018) 155:141\u20139. \u00a010.1016/j.bcp.2018.06.016", "ArticleIdList": ["10.1016/j.bcp.2018.06.016", "PMC6594173", "29935959"]}, {"Citation": "Wang K, Lv Q, Miao Ym, Qiao Sm, Dai Y, Wei Zf. Cardamonin, a Natural Flavone, Alleviates Inflammatory Bowel Disease by the Inhibition of NLRP3 Inflammasome Activation Via an AhR/Nrf2/NQO1 Pathway. Biochem Pharmacol (2018) 155:494\u2013509. \u00a010.1016/j.bcp.2018.07.039", "ArticleIdList": ["10.1016/j.bcp.2018.07.039", "30071202"]}, {"Citation": "Lv Q, Shi C, Qiao S, Cao N, Guan C, Dai Y, et al. . Alpinetin Exerts Anti-Colitis Efficacy by Activating AhR, Regulating miR-302/DNMT-1/CREB Signals, and Therefore Promoting Treg Differentiation. Cell Death Dis (2018) 9:1\u201325. \u00a010.1038/s41419-018-0814-4", "ArticleIdList": ["10.1038/s41419-018-0814-4", "PMC6117360", "30166541"]}, {"Citation": "Wang HK, Yeh CH, Iwamoto T, Satsu H, Shimizu M, Totsuka M. Dietary Flavonoid Naringenin Induces Regulatory T Cells Via an Aryl Hydrocarbon Receptor Mediated Pathway. J Agric Food Chem (2012) 60:2171\u20138. \u00a010.1021/jf204625y", "ArticleIdList": ["10.1021/jf204625y", "22324845"]}, {"Citation": "Miron A, Aprotosoaie AC, Trifan A, Xiao J. Flavonoids as Modulators of Metabolic Enzymes and Drug Transporters. Ann NY Acad Sci (2017) 1398:152\u201367. \u00a010.1111/nyas.13384", "ArticleIdList": ["10.1111/nyas.13384", "28632894"]}, {"Citation": "Van Der Woude H, Boersma MG, Vervoort J, Rietjens IMCM. Identification of 14 Quercetin Phase II Mono- and Mixed Conjugates and Their Formation by Rat and Human Phase II In Vitro Model Systems. Chem Res Toxicol (2004) 17:1520\u201330. \u00a010.1021/tx049826v", "ArticleIdList": ["10.1021/tx049826v", "15540950"]}, {"Citation": "Murota K, Nakamura Y, Uehara M. Flavonoid Metabolism: The Interaction of Metabolites and Gut Microbiota. Biosci Biotechnol Biochem (2018) 82:600\u201310. \u00a010.1080/09168451.2018.1444467", "ArticleIdList": ["10.1080/09168451.2018.1444467", "29504827"]}, {"Citation": "Ray SK, Mukherjee S. Evolving Interplay Between Dietary Polyphenols and Gut Microbiota\u2014An Emerging Importance in Healthcare. Front Nutr (2021) 8:197\u2013203. \u00a010.3389/fnut.2021.634944", "ArticleIdList": ["10.3389/fnut.2021.634944", "PMC8180580", "34109202"]}, {"Citation": "Murray IA, Patterson AD, Perdew GH. Aryl Hydrocarbon Receptor Ligands in Cancer: Friend and Foe. Nat Rev Cancer (2014) 14:801\u201314. \u00a010.1038/nrc3846", "ArticleIdList": ["10.1038/nrc3846", "PMC4401080", "25568920"]}, {"Citation": "Zhang S, Qin C, Safe SH. Brogan & Partners Flavonoids as Aryl Hydrocarbon Receptor Agonists/Antagonists: Effects of Structure and Cell Context. Environ Health Perspect (2014) 111:1877\u201382. \u00a010.1289/ehp.6322", "ArticleIdList": ["10.1289/ehp.6322", "PMC1241760", "14644660"]}, {"Citation": "Zhang S, Qin C, Safe SH. Flavonoids as Aryl Hydrocarbon Receptor Agonists/Antagonists: Effects of Structure and Cell Context. Environ Health Perspect (2003) 111:1877\u201382. \u00a010.1289/ehp.6322", "ArticleIdList": ["10.1289/ehp.6322", "PMC1241760", "14644660"]}, {"Citation": "Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, et al. . An Endogenous Tumour-Promoting Ligand of the Human Aryl Hydrocarbon Receptor. Nature (2011) 478:197\u2013203. \u00a010.1038/nature10491", "ArticleIdList": ["10.1038/nature10491", "21976023"]}, {"Citation": "Amado NG, Fonseca BF, Cerqueira DM, Neto VM, Abreu JG. Flavonoids: Potential Wnt/Beta-Catenin Signaling Modulators in Cancer. Life Sci (2011) 89:545\u201354. \u00a010.1016/j.lfs.2011.05.003", "ArticleIdList": ["10.1016/j.lfs.2011.05.003", "21635906"]}, {"Citation": "Safe S, Jin UH, Park H, Chapkin RS, Jayaraman A. Aryl Hydrocarbon Receptor (AHR) Ligands as Selective Ahr Modulators (SAHRMS). Int J Mol Sci (2020) 21:1\u201316. \u00a010.3390/ijms21186654", "ArticleIdList": ["10.3390/ijms21186654", "PMC7555580", "32932962"]}, {"Citation": "Yang T, Feng YL, Chen L, Vaziri ND, Zhao YY. Dietary Natural Flavonoids Treating Cancer by Targeting Aryl Hydrocarbon Receptor. Crit Rev Toxicol (2019) 49:445\u201360. \u00a010.1080/10408444.2019.1635987", "ArticleIdList": ["10.1080/10408444.2019.1635987", "31433724"]}, {"Citation": "Altemimi A, Lakhssassi N, Baharlouei A, Watson DG, Lightfoot DA. Phytochemicals: Extraction, Isolation, and Identification of Bioactive Compounds From Plant Extracts. Plants (2017) 6:445\u201360. \u00a010.3390/plants6040042", "ArticleIdList": ["10.3390/plants6040042", "PMC5750618", "28937585"]}, {"Citation": "Do QD, Angkawijaya AE, Tran-Nguyen PL, Huynh LH, Soetaredjo FE, Ismadji S, et al. . Effect of Extraction Solvent on Total Phenol Content, Total Flavonoid Content, and Antioxidant Activity of Limnophila Aromatica. J\u00a0Food Drug Anal (2014) 22:296\u2013302. \u00a010.1016/j.jfda.2013.11.001", "ArticleIdList": ["10.1016/j.jfda.2013.11.001", "PMC9354875", "28911418"]}, {"Citation": "Ahmad MZ, Alkahtani SA, Akhter S, Ahmad FJ, Ahmad J, Akhtar MS, et al. . Progress in Nanotechnology-Based Drug Carrier in Designing of Curcumin Nanomedicines for Cancer Therapy: Current State-of-the-Art. J Drug Target (2016) 24:273\u201393. \u00a010.3109/1061186X.2015.1055570", "ArticleIdList": ["10.3109/1061186X.2015.1055570", "26066739"]}, {"Citation": "Coradini K, Lima FO, Oliveira CM, Chaves PS, Athayde ML, Carvalho LM, et al. . Co-Encapsulation of Resveratrol and Curcumin in Lipid-Core Nanocapsules Improves Their In Vitro Antioxidant Effects. Eur J Pharm Biopharm (2014) 88:178\u201385. \u00a010.1016/j.ejpb.2014.04.009", "ArticleIdList": ["10.1016/j.ejpb.2014.04.009", "24780440"]}, {"Citation": "Takahashi M, Uechi S, Takara K, Asikin Y, Wada K. Evaluation of an Oral Carrier System in Rats: Bioavailability and Antioxidant Properties of Liposome-Encapsulated Curcumin. J Agric Food Chem (2009) 57:9141\u20136. \u00a010.1021/jf9013923", "ArticleIdList": ["10.1021/jf9013923", "19757811"]}, {"Citation": "Ko SG, Yin CS, Du B, Kim K. Herbal Medicines for Inflammatory Diseases. Mediators Inflamm (2014) 2014:982635. \u00a010.1155/2014/982635", "ArticleIdList": ["10.1155/2014/982635", "PMC4290032", "25609893"]}, {"Citation": "Li F, Weng J. Demystifying Traditional Herbal Medicine With. Nat Publ Group (2017) 3:1\u20137. \u00a010.1038/nplants.2017.109", "ArticleIdList": ["10.1038/nplants.2017.109", "28758992"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "4", "Day": "20"}, {"Year": "2021", "Month": "6", "Day": "8"}, {"Year": "2021", "Month": "7", "Day": "12", "Hour": "5", "Minute": "48"}, {"Year": "2021", "Month": "7", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["34249001", "PMC8264659", "10.3389/fimmu.2021.697663"]}}], "PubmedBookArticle": []}